Immune prognostic factors in ovarian cancer: lessons from translational research

Dis Markers. 2007;23(5-6):445-52. doi: 10.1155/2007/508350.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antibodies, Neoplasm / analysis
  • Biomarkers, Tumor / analysis*
  • Female
  • Humans
  • Immune Tolerance*
  • Major Histocompatibility Complex
  • Ovarian Neoplasms / diagnosis*
  • Ovarian Neoplasms / immunology*
  • Prognosis

Substances

  • Antibodies, Neoplasm
  • Biomarkers, Tumor